Healthcare MoneyTree™ report: Q1 2019

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.

PwC and CB Insights' Healthcare MoneyTree™ report brings you a quarterly publication based on US venture capital funding for healthcare related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers, and Global healthcare trends.

For full analysis of Q1'19 activity across all sectors, refer to the PwC/CB Insights MoneyTree™ Report.

US Healthcare deal share by stage

Early and expansion stage deals made up the majority of deals.

 

Highlights for this quarter's report include, but are not limited to:

  • Dollars invested in US Healthcare slightly increased quarter to quarter at $4.17B in Q4’18 to $4.22B in Q1’19.
  • Median deal size for Early and Later stage companies increased, hitting $10.9M and $29.8M respectively. With an active IPO market, many later stage companies are opting for the IPO route vs raise private dollars.
  • US Healthcare mega-round financing raised $1.6B in Q1’19, which was a 38% increase from the mega-round funding in the prior quarter.
  • Silicon Valley is above New England in dollars invested in Q1’19, with $1,369 M raised this quarter through 31 deals.

Contact us

Greg Vlahos

Partner, US Pharmaceuticals and Life Sciences, PwC US

Laura Robinette

US Pharmaceutical & Life Sciences Assurance Leader, PwC US

Tim Weld

US Health Industries Assurance Leader, PwC US

Follow us